Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice

Virology

Volumn 218, Issue 1, 1996, Pages 61-70

  Yimn, Tae Ji ^a,b   Tang, Shenbei ^a   Andino, Raul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HUMORAL IMMUNITY; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VACCINATION; VIRUS RECOMBINANT;

EID: 0342624750     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0166     Document Type: Article

References (29)

1. Alexander, L., Lu, H. H., and Wimmer, E. (1994). Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: Genetic hybrids and the expression of a foreign gene. Proc. Natl. Acad. Sci. USA 91, 1406-1410.
2. Altmeyer, R., Escriou, N., Girard, M., Palmenberg, A., and van der Werf, S. (1994). Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120. Proc. Natl. Acad. Sci. USA 91, 9775-9779.
3. Altmeyer, R., Girard, M., Van Der Werf, S., Mimic, V., Seigneur, L., and Saron, M. (1995). Attenuated Mengo virus: A new vector for live Recombinant vaccine. J. Virol. 69, 3193-3196.
4. Andino, R. (1994). Unpublished results.
5. Andino, R., Rieckhof, G. E., Achacoso, P. D., and Baltimore, D. (1993). Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. Embo. J. 12, 3587-3598.
6. Andino, R., Silvera, D., Suggett, S. D., Achacoso, P. L., Miller, C. J., Baltimore, D., and Feinberg, M. B. (1994). Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science 265, 1448-1451.
7. Ansardi, D. C., Pal Ghosh, R., Porter, D., and Morrow, C. D. (1995). Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase. J. Virol. 69, 1359-1366.
8. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1994). Curr. Protocols Mol. Biol. 1, 3.0.1-3.19.8.
9. Bernstein, H. D., Sonenberg, N., and Baltimore, D. (1985). Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol. Cell. Biol. 5, 2913-2923.
10. Burke, K. L., Almond, J. W., and Evans, D. J. (1991). Antigen chimeras of poliovirus. Prog. Med. Virol. 38, 56-68.
11. Burke, K. L., Dunn, G., Ferguson, M., Minor, P. D., and Almond, J. W. (1988). Antigen chimaeras of poliovirus as potential new vaccines. Nature 332, 81-82.
12. Choi, W. S., Pal-Ghosh, R., and Morrow, C. D. (1991). Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons. J. Virol. 65, 2875-2883.
13. Clarke, B. E., Newton, S. E., Carroll, A. R., Francis, M. J., Appleyard, G., Syred, A. D., Highfield, P. E., Rowlands, D. J., and Brown, F. (1988). Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Br. Med. J. (Clin. Res. Ed.) 296, 381-384.
14. Crowther, R. A., Kiselev, N. A., Bottcher, B., Berriman, J. A., Borisova, G. P., Ose, V., and Pumpens, P. (1994). Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77, 943-950.
15. Dowdle, W. R., and Orenstein, W. A. (1994). Quest for life-long protection by vaccination. Proc. Natl. Acad. Sci. USA 91, 2464-2468.
16. Evans, D. J., McKeating, J., Meredith, J. M., Burke, K. L., Katrak, K., John, A., Ferguson, M., Minor, P. D., Weiss, R. A., and Almond, J. W. (1989). An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385-388.
17. Hollinger, F. B. (1990). Hepatitis B virus. In "Virology" (B. N. Fields and D. M. Knipe, et al.), pp. 2171-2236. Raven Press, New York.
18. Krugman, S. (1988). Hepatitis B vaccine. In Vaccines (S. A. Plotkin and E. A. Mortimer, Jr., Eds.), pp. 458-473. Saunders, Philadelphia.
19. La Montagne, J. R., and Rabinovich, R. (1992). Challenges and opportunities in vaccine research. In "Genetically Engineered Vaccines" (J. E. Ciardi, J. R. McGhee, and J. M. Keith, Eds.), pp. 293-299. Plenum Press, New York.
20. Lu, H., Alexander, L., and Wimmer, E. (1995). Construction and genetic analysis od dicistronic polioviruses containing open reading frame for epitopes of human Immunodeficiency virus type 1 gp120. J. Virol. 69, 4797-4806.
21. Luthman, H., and Magnusson, G. (1983). High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res. 11, 1295-1308.
22. Mattion, N. M., Reilly, P. A., DiMichele, S. J., Crowley, J. C., and Weeks-Levy, C. (1994). Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses. J. Virol. 68, 3925-3933.
23. Milich, D. R., McLachlan, A., Moriarty, A., and Thornton, G. B. (1987). Immune response to hepatitis B virus core antigen (HBcAg): Localization of T cell recognition sites within HBcAg/HBeAg. Nature 329, 547-549.
24. Porter, D. C., Ansardi, D. C., and Morrow, C. D. (1995). Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans. J. Virol. 69, 1548-1555.
25. Ren, R. B., Costantini, F., Gorgacz, E. J., Lee, J. J., and Racaniello, V. R. (1990). Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63, 353-362.
26. Schodel, F., Moriarty, A. M., Peterson, D. L., Zheng, J. A., Hughes, J. L., Will, H., Leturcq, D. J., McGee, J. S., and Milich, D. R. (1993). The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J. Virol. 66, 106-114.
27. Smith, D. B., and Johnson, K. S. (1988). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione Stransferase. Gene 67, 31-40.
28. Trono, D., Andino, R., and Baltimore, D. (1988). An RNA sequence of hundreds of nucleotides at the 5′ end of poliovirus RNA is involved in allowing viral protein synthesis. J. Virol. 62, 2291-2299.
29. Zhou, S. L., and Standring, D. N. (1991). Production of hepatitis B virus nucleocapsidlike core particles in Xenopus oocytes: Assembly occurs mainly in the cytoplasm and does not require the nucleus. J. Virol. 65, 5457-5464.